Cost effectiveness of breast cancer screening using mammography; a systematic review

Iranian Journal of Public Health

Volumn 42, Issue 4, 2013, Pages 347-357

  Rashidian, Arash ^a,b   Barfar, Eshagh ^a,c   Hosseini, Hamed ^a,b   Nosratnejad, Shirin ^a   Barooti, Esmat ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Breast cancer; Cost effectiveness; Screening; Systematic review

Indexed keywords

EID: 84879188932     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global Cancer Statistics, 2002. CA Cancer J Clin, 55(2): 74-108.
2. Breast Health Global Initiative (2010). Pan American Health Organization (Regional Office of the World Health Organization). Available from: http://www.paho.org/english/ad/ bhgi-about.htm.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009). Cancer statistics, 2009. CA Cancer J Clin, 59(4):225-49.
4. Okobia MN, Bunker CH, Okonofua FE, Osime U (2006). Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol, 4:11.
5. Kahan E, Ibrahim AS, El Najjar K, Ron E, Al-Agha H, Polliack A, et al. (1997). Cancer patterns in the Middle East--special report from the Middle East Cancer Society. Acta Oncol, 36(6):631-6.
6. IARC (2008). World Cancer Report 2008. In: Cancer site by site. International Agency for Research on Cancer. Lyon. 412-418.
7. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ (2004). Breast cancer: results of a multicenter study. Asian Pac J Cancer Prev, 5(1):24-27.
8. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, et al. (1998). Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol, 27(5):735-42.
9. Maurer F (1997). A peer education model for teaching breast self-examination to women. Cancer Nurs, 20(1):49-61.
10. de Koning HJ (2003). Mammographic screening: evidence from randomised controlled trials. Ann Oncol, 14(8):1185-9.
11. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography (2009). Cochrane Database Syst Rev, 4(1).
12. Rajan A, Gutierrez-Ibarluzea I, Moharra M (2011). Addressing issues assessment promotion: Motives, enablers, and barriers. Int J Technol Assess Health Care, 27(01):55-63.
13. Hajarizadeh B, Rashidian A, Haghdoost AA, Alavian SM (2011). Estimating the costs of the mass vaccination campaign against Hepatitis B in Iranian adolescents. Govaresh, 14(1): 27-34.
14. Soleymani F, Rashidian A, Dinarvand R, Kebriaeezade A, Hosseini M, Abdollahi M (2012). Assessing the effectiveness and cost-effectiveness of audit and feedback on physician's prescribing indicators: study protocol of a randomized controlled trial with economic evaluation. DARU Journal of Pharmaceutical Sciences 20:88.
15. rd ed. Oxford: Oxford University Press. UK.
16. Radice D, Redaelli A (2003). Breast cancer management: quality-of-life and cost considerations. Pharmacoecon, 21(6):383-96.
17. Yousefi Nooraie R, Rashidian A, Nedjat S, Majdzadeh R, Mortaz Hejri SO, Etemadi A, Salmasian H (2009). Promoting development and use of systematic reviews in a developing country. J Eval Clin Pract, 15(6):1029-34.
18. Rashidian A (2008). Adapting valid clinical guidelines for use in primary care. Prim Care Respir J 2008, 17(3):136-7.
19. Brown M, Fintor L (1993). Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat, 25(2):113-18.
20. Hall J, Gerard K, Salkeld G, Richardson J (1992). A cost utility analysis of mammography screening in Australia. Soc Sci Med, 34(9):993.
21. Mushlin A, Fintor L (1992). Is screening for breast cancer cost-effective? Cancer, 69(S7):1957-62.
22. Zappa M, Visioli C, Ciatto S (2003). Mammography screening in elderly women: efficacy and cost-effectiveness. Crit Rev Oncol Hematol, 46(3):235-39.
23. Brown D, French M, Schweitzer M, McGeary K, McCoy C, Ullmann S (1999). Economic evaluation of breast cancer screening: A review. Cancer Pract, 7(1):28-33.
24. Elixhauser A (1991). Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care, 7(04):604-15.
25. Clark R (1992). Economic issues in screening mammography. Am J Roentgenol, 158(3):527.
26. Fraser N, Clarke P (1992). Cost-effectiveness of breast cancer screening. Breast, 1(4):169-72.
27. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu A, Atkins D, et al (2003). The Cost-Effectiveness of Screening Mammography beyond Age 65 Years: a systematic review for u. s preventive srvices. Ann Intern Med, 139(10):835.
28. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ (2008). Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst, 100(18):1290-300.
29. Woo P, Kim J, Leung G (2007). What is the most cost-effective population-based cancer screening program for Chinese women?. J Clin Oncol, 25(6):617.
30. Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM (2007). Cost effectiveness of mammography screening for Chinese women. Cancer, 110(4):885-95.
31. Rosenquist C, Lindfors K (1994). Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiol, 191(3):647.
32. Salzmann P, Kerlikowske K, Phillips K (1997). Cost effectiveness of extending screening mammography guidlines to include women 40 to 49 years of age. Ann Intern Med, 127:955-65.
33. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG (2006). Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst, 98(11):774-82.
34. Lindfors K, Rosenquist C (1995). The cost-effectiveness of mammographic screening strategies. JAMA, 274(11):881.
35. Rosenquist C, Lindfors K (1998). Screening mammography beginning at age 40 years A Reappraisal of Cost Effectiveness. Cancer, 82(11):2235-40.
36. van Ineveld B, van Oortmarssen G, de Koning H, Boer R, van der Maas P (1993). How cost-effective is breast cancer screening in different EC countries?. Eur J Cancer, 29(12):1663-68.
37. Groot M, Baltussen R, Uylde Groot C, Anderson B, Hortobágyi G (2006). Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J, 12(1):81.
38. Boer R, De Koning H, Van Oortmarssen G, Van Der Maas P (1995). In search of the best upper age limit for breast cancer screening. Eur J Cancer, 31(12):2040-43.
39. Carter R, Glasziou P, Van Oortmarssen G, De Koning H, Stevenson C, Salkeld G, et al (1993). Cost-effectiveness of mammographic screening in Australia. Aust J Pub Health, 17(1).
40. Barratt AL, Irwig LM, Glasziou PP, Salkeld GP, Houssami N (2002). Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review. Med J Aust, 176(6):266-71.
41. Hakama M, Hristova L (1997). Effect of screening in the Nordic cancer control up to the year 2017. Acta Oncol, 36(2):119-28.
42. Leivo T, Sintonen H, Tuominen R, Hakama M, Pukkala E, Heinonen O (1999). The cost effectiveness of nationwide breast carcinoma screening, 1987-1992. Cancer, 86(4):638-46.
43. Norum J (1999). Breast cancer screening by mammography in Norway. Is it cost-effective?. Ann Oncol, 10(2):197-203.
44. Wang H, Kåresen R, Hervik A, Thoresen S (2001). Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control, 12(1):39-45.
45. Boer R, De Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, et al (1998). Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ, 317(7155):376.
46. Madan J, Rawdin A, Stevenson M, Tappenden P (2010). A Rapid Response Economic Evaluation of the UK NHS Cancer Reform Strategy Breast Cancer Screening Program Extension via a Plausible Bounds Approach. Value Health, 13(2):215-21.
47. Arveux P, Wait S, Schaffer P (2003). Building a model to determine the cost-effectiveness of breast cancer screening in France. Eur J Cancer Care, 12(2):143-53.
48. Beemsterboer P, De Koning H, Warmerdam P, Boer R, Swart E, Dierks M, et al (1994). Prediction of the effects and costs of breast-cancer screening. Int J Cancer, 58(5):623-28.
49. de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, et al (2009). Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer, 45(1):127-38.
50. Szeto K, Devlin N (1996). The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy, 38(2):101-15.
51. Plans P, Casademont L, Salleras L (1996). Cost-effectiveness of breast cancer screening in Spain. Int J Technol Assess Health Care, 12(01):146-50.
52. Lee SY, Jeong SH, Kim YN, Kim J, Kang DR, Kim HC, et al (2009). Cost-effective mammography screening in Korea: high incidence of breast cancer in young women. Cancer Sci, 100(6):1105.
53. Rojnik K, Naversnik K, Mateovic-Rojnik T, Primiczakelj M (2008). Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. Value Health, 11(2):139-48.
54. Omidvari AH, Vali Y, Murray S, Wonderling D, Rashidian A (2013). Nutritional screening for improving professional practice for patient outcomes in hospital and primary care settings. Cochrane Database Syst Rev (in press).
55. Murillo R, Díaz S, Sánchez O, Perry F, Piñeros M, Poveda C, et al (2008). Pilot implementation of breast cancer early detection programs in Colombia. Breast Care, 3(1):29.
56. Denny L, Quinn M, Sankaranarayanan R (2006). Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24 (3): S71-S77.
57. Alliance for Cervical Cancer Prevention (2004). The Case for Investing in Cervical Cancer Prevention. Seattle: ACCP. Cervical Cancer Prevention Issues in Depth, No. 3.